Compare TRST & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRST | OPK |
|---|---|---|
| Founded | 1902 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 858.9M | 921.2M |
| IPO Year | 1994 | 2011 |
| Metric | TRST | OPK |
|---|---|---|
| Price | $50.48 | $1.29 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $1.60 |
| AVG Volume (30 Days) | 67.4K | ★ 2.3M |
| Earning Date | 04-21-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | ★ 26.46 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.24 |
| P/E Ratio | $55.44 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.17 | $0.98 |
| 52 Week High | $50.52 | $1.60 |
| Indicator | TRST | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 67.76 | 71.83 |
| Support Level | $41.96 | $1.28 |
| Resistance Level | N/A | $1.42 |
| Average True Range (ATR) | 0.89 | 0.04 |
| MACD | 0.11 | 0.02 |
| Stochastic Oscillator | 82.95 | 93.33 |
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.